Bausch Health (BHC) Companies announced the results of the special meeting of shareholders held on October 7, 2025. At the Shareholders Meeting, shareholders of the Company approved the ratification, confirmation and approval of the adoption of the Company’s Amended and Restated Shareholder Rights Plan Agreement dated April 14, 2025, as amended and restated on August 25, 2025, as described in detail in the Company’s Management Proxy Circular and Proxy Statement dated August 27, 2025.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHC:
- Bausch Health’s Solta Medical featured on ‘The Balancing Act’
- Bausch Health’s OraPharma introduces ‘OraTalks’ podcast
- Bausch Health completes acquisition of DURECT Corporation
- Solta Medical surpasses 5M skin tightening treatments with Thermage
- Bausch Health announces extension of Durect tender offer